4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-063518
Options or other derivatives
- Director acquired 29,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hohneker John Director | 2024-05-16 | Grant or award · Stock Option (right to buy) | +29,550 | 29,550 | D: show line 1 in the form |
Loading xslF345X05/tm2414893-2_4seq1.xml…